Can a single chat with a partner keep people who inject drugs in care?

NCT ID NCT07631559

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This pilot study tests a one-time 'booster' session for people who inject drugs and their injecting partners, given right after finishing hepatitis C treatment. The session helps them set health goals, identify barriers, and improve communication to stay engaged in ongoing healthcare. Researchers will enroll 50 adults in San Francisco to see if the session is acceptable and feasible.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
partner navigation intervention booster session
What this could lead to
If successful, this could point toward a simple, low-cost way to help people who inject drugs stay connected to healthcare after finishing hepatitis C treatment.
What could go wrong
This is a very small pilot study (50 people) testing only feasibility and acceptability, not whether the session actually improves health. It may not work in other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG USE DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Quaker Meeting House

    San Francisco, California, 94103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.